Israel Englander’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Sell
50,000
-96,300
-66% -$4.04M ﹤0.01% 3499
2026
Q1
$4.71M Buy
+146,300
New +$5.42M ﹤0.01% 3014
2025
Q1
Sell
-100,000
Closed -$3.96M 6430
2024
Q4
$3.96M Sell
100,000
-300
-0.3% -$11.4K ﹤0.01% 3030
2024
Q3
$3.41M Buy
+100,300
New +$2.82M ﹤0.01% 3187
2024
Q1
Sell
-50,000
Closed -$1.38M 6689
2023
Q4
$1.38M Sell
50,000
-50,000
-50% -$1.21M ﹤0.01% 3906
2023
Q3
$2.23M Buy
+100,000
New +$2.57M ﹤0.01% 3453
2021
Q2
Sell
-100,000
Closed -$5.38M 7142
2021
Q1
$5.38M Buy
100,000
+48,000
+92% +$2.76M ﹤0.01% 2491
2020
Q4
$2.54M Buy
+52,000
New +$2.41M ﹤0.01% 3040

Other funds holding VCYT

Israel Englander's VCYT Position: Q2 2026 in Review

Israel Englander opened a new position in Veracyte (VCYT) in Q2 2026: 71,982 shares worth $4.23M. The stake represents ﹤0.01% of the portfolio and ranks #3146 among its holdings. This is a return to the name: Israel Englander previously reported a position in VCYT as recently as Q4 2025.

Israel Englander first reported a position in VCYT in Q4 2013 and has held it in 46 quarters since. The position peaked at $20.5M in Q1 2019. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Israel Englander held 71,982 shares of Veracyte worth $4.23M as of Q2 2026.
  • Veracyte was a new Israel Englander position in Q2 2026.
  • Veracyte made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3146 holding.
  • Israel Englander first reported a position in Veracyte in Q4 2013 and has held it in 46 quarters since.
  • Israel Englander's Veracyte position peaked at $20.5M in Q1 2019.
  • 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.